CYP19A1 and breast cancer: When NR4A2 expression and activity are depleted in isolated human ASCs, there is a substantial increase in aromatase gene expression and, therefore, estrogen biosynthesis, increasing the likelihood of breast cancer occurrence (Ghosh et al., 2010).